Teyi Pharmaceutical Soars 10% to Hit Intraday High of CNY 8.80

Teyi Pharmaceutical Group Co., Ltd. has experienced significant activity today, with the stock rising by 10.0% and reaching an intraday high of CNY 8.80. This performance stands in contrast to the China Shanghai Composite, which only gained 1.16% on the same day. Over the past week, Teyi has shown a robust increase of 9.73%, while the broader index has declined by 2.14%. Despite this positive momentum, Teyi's longer-term performance reveals challenges. The stock has seen a year-to-date decline of 18.89% and a three-year drop of 41.49%, indicating consistent underperformance against the benchmark. Financial metrics show that net sales for the most recent quarter fell by 28.89%, and the company has a low inventory turnover ratio of 1.38 times. With a market capitalization of CNY 3,094 million, Teyi operates within the pharmaceuticals and biotechnology sector. The company has a return on equity of 4.11% and a price-to-book ratio of 1.67, reflecting its current valuation in the market.